Cohen Cheryl — SEC Form 4 filings
SEC reporting owner CIK 1529371. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-13 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 131,210 shares, $1,246,941 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 131,210 shares @ $9.50 ($1,246,941) in ImmunityBio, Inc., filed 2026-07-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | Director | 4 | — | 1 leg · 131,210 sh · $1,246,941 | 5 |
| Celldex Therapeutics, Inc. (CLDX) | Director | 3 | — | — | 3 |
Form 4 filings — Cohen Cheryl
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 55,979 @ $2.98 · Sale (S): 131,210 @ $9.50 · Option exercise (M): 55,979 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 77,633 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1529371 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →